跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-LURASIDONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-LURASIDONE
Authorized
STANDARD
TARO-LURASIDONE
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
fcd50f48481c2b56
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
fcd50f48481c2b56
Drug Approval Canada Name
TARO-LURASIDONE
Product Name
TARO-LURASIDONE
Status
Marketed
Status Date
2022-05-02
Original Market Date
2022-05-02
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
28:16.08.04
Atc Original
N05AE05 LURASIDONE
Aig Number
0153185004
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive Brampton Ontario Canada L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
fcd50f48481c2b56
Type
Standard
Back to Health Canada Approvals